Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Lenocta sodium stibogluconate: Phase IIa started

VQPH began an open-label, U.S. Phase IIa trial of 1,125 mg/m 2

Read the full 126 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE